Outcome Assessment
depressive, Anxiety
SECONDARY
We followed up participants at 2-month intervals for a total of 12 months post randomization, ending June 30, 2020. The primary outcome was the rate of depressive symptom episodes, operationalized as elevations to the moderately severe threshold; we conducted sensitivity analyses using the severe symptom threshold. Anxiety symptoms, a secondary outcome, were assessed concurrently.Additional outcomes included engagement and retention with mental health services, measured by the National Institute of Mental Health’s Collaborative Psychiatric Epidemiology Studies.